2026 H1 - tulosraportti
65 päivää sitten
‧45 min
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 10 852 | ||
| 10 000 | ||
| 1 500 | ||
| 7 648 | ||
| 4 899 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H2 - tulosraportti 26.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 H1 - tulosraportti 28.8. | ||
2025 H2 - tulosraportti 26.2. | ||
2025 H1 - tulosraportti 29.8.2025 | ||
2024 H2 - tulosraportti 26.2.2025 | ||
2024 H1 - tulosraportti 30.8.2024 |
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
·5 t sittenMuch is being written about crashes, interest rates, and all the things that might go wrong. I prefer to look at what Thor Medical has actually delivered – and where the company could stand in the coming years. AlphaOne was completed on time and on budget. Production has started, customers are receiving deliveries, and new multi-year agreements are coming in. Thor has around 850 million NOK in concluded delivery agreements, and the company expects increasing production and deliveries from AlphaOne. (thormedical.com) And this is not a small Norwegian experiment. Globally, massive investments are being made in targeted radioactive cancer treatment. Thor itself states that the number of published development programs based on Pb-212 and Ra-224 has more than doubled since 2025, and Pb-212 is now among the leading isotopes in the development of new alpha treatments. (thormedical.com) Companies are not doing this for fun. Billions are being invested because the clinical results in several places look promising. If Thor continues to deliver, and AlphaOne shows increasing sales through 2027, I personally do not think 7.50–10.00 NOK is an unrealistic scenario. Arctic has previously set a target price of 8.70 NOK before we have even seen the full commercial effect of AlphaOne. (Finansavisen) If larger contracts, higher production volume, and one or more Pb-212 treatments then move closer to commercial use, the market can begin to look much further ahead. Then, in my opinion, 10.00–15.00 NOK could become a relevant positive scenario – not a promise, but a possible outcome if the business develops strongly. AlphaOne is designed for approximately 21,000 patient doses and around 350 million NOK in annual revenue potential after three years of operation, and Thor expects EBITDA break-even in 2027. (thormedical.com) So yes, the market is restless right now, and some choose to sell. They are of course welcome to do that. I choose to look 1, 2, and 3 years ahead. Because if Thor continues to adhere to its plans, more customers join, and Pb-212 develops into the cancer treatment that so many companies worldwide are betting on, then I do not think the story of Thor Medical ends at 4 or 5 kroner. In my view, it has only just begun. And those who are left standing on the platform once the train has left must decide for themselves whether they want to run after it.
·1 päivä sittenCurious how much trmed will be affected by a potential crash.. feel they are a bit on the side, that they are not as dependent on the stock market as stocks in general. More and more (and more) (an) indicate that a crash could happen in the near future!! Considering selling out with GAV 2.92. Or will you sit tight in the event of a potential crash.. Some thoughts. ??
When it went to hell last time, where did the boost come from. What went to heaven?
·2 päivää sitten(Guess I'll take one then) Ahhh, stocks on sale. That's the best thing I know, buy buy buy. Life is so loooovely❤️❤️❤️❤️ All I want is for stocks to go down so I get to buy buy buy. Because I have endless capital, that's why I am here on Nordnet. Oooooh, if only Thor had gone down below 3.8, then I would have bought even more. We'll have to count on that for Monday. Stocks that rise are for dopes. I want a downturn to buy more and more and more❤️ I never make a mistake, if I buy on sale now then I don't write that I am unlucky with my investments, but rather write a new post where I write that I buy even more. Because smart people buy more stocks when the stock plunges. Because I have read that Mr Warren Bucket does that. Happy weekend and cheers to stocks on sale!!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 H1 - tulosraportti
65 päivää sitten
‧45 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·5 t sittenMuch is being written about crashes, interest rates, and all the things that might go wrong. I prefer to look at what Thor Medical has actually delivered – and where the company could stand in the coming years. AlphaOne was completed on time and on budget. Production has started, customers are receiving deliveries, and new multi-year agreements are coming in. Thor has around 850 million NOK in concluded delivery agreements, and the company expects increasing production and deliveries from AlphaOne. (thormedical.com) And this is not a small Norwegian experiment. Globally, massive investments are being made in targeted radioactive cancer treatment. Thor itself states that the number of published development programs based on Pb-212 and Ra-224 has more than doubled since 2025, and Pb-212 is now among the leading isotopes in the development of new alpha treatments. (thormedical.com) Companies are not doing this for fun. Billions are being invested because the clinical results in several places look promising. If Thor continues to deliver, and AlphaOne shows increasing sales through 2027, I personally do not think 7.50–10.00 NOK is an unrealistic scenario. Arctic has previously set a target price of 8.70 NOK before we have even seen the full commercial effect of AlphaOne. (Finansavisen) If larger contracts, higher production volume, and one or more Pb-212 treatments then move closer to commercial use, the market can begin to look much further ahead. Then, in my opinion, 10.00–15.00 NOK could become a relevant positive scenario – not a promise, but a possible outcome if the business develops strongly. AlphaOne is designed for approximately 21,000 patient doses and around 350 million NOK in annual revenue potential after three years of operation, and Thor expects EBITDA break-even in 2027. (thormedical.com) So yes, the market is restless right now, and some choose to sell. They are of course welcome to do that. I choose to look 1, 2, and 3 years ahead. Because if Thor continues to adhere to its plans, more customers join, and Pb-212 develops into the cancer treatment that so many companies worldwide are betting on, then I do not think the story of Thor Medical ends at 4 or 5 kroner. In my view, it has only just begun. And those who are left standing on the platform once the train has left must decide for themselves whether they want to run after it.
- ·1 päivä sittenCurious how much trmed will be affected by a potential crash.. feel they are a bit on the side, that they are not as dependent on the stock market as stocks in general. More and more (and more) (an) indicate that a crash could happen in the near future!! Considering selling out with GAV 2.92. Or will you sit tight in the event of a potential crash.. Some thoughts. ??When it went to hell last time, where did the boost come from. What went to heaven?
- ·2 päivää sitten(Guess I'll take one then) Ahhh, stocks on sale. That's the best thing I know, buy buy buy. Life is so loooovely❤️❤️❤️❤️ All I want is for stocks to go down so I get to buy buy buy. Because I have endless capital, that's why I am here on Nordnet. Oooooh, if only Thor had gone down below 3.8, then I would have bought even more. We'll have to count on that for Monday. Stocks that rise are for dopes. I want a downturn to buy more and more and more❤️ I never make a mistake, if I buy on sale now then I don't write that I am unlucky with my investments, but rather write a new post where I write that I buy even more. Because smart people buy more stocks when the stock plunges. Because I have read that Mr Warren Bucket does that. Happy weekend and cheers to stocks on sale!!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 10 852 | ||
| 10 000 | ||
| 1 500 | ||
| 7 648 | ||
| 4 899 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H2 - tulosraportti 26.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 H1 - tulosraportti 28.8. | ||
2025 H2 - tulosraportti 26.2. | ||
2025 H1 - tulosraportti 29.8.2025 | ||
2024 H2 - tulosraportti 26.2.2025 | ||
2024 H1 - tulosraportti 30.8.2024 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 H1 - tulosraportti
65 päivää sitten
‧45 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 H2 - tulosraportti 26.2.2027 |
| Menneet tapahtumat | ||
|---|---|---|
2026 H1 - tulosraportti 28.8. | ||
2025 H2 - tulosraportti 26.2. | ||
2025 H1 - tulosraportti 29.8.2025 | ||
2024 H2 - tulosraportti 26.2.2025 | ||
2024 H1 - tulosraportti 30.8.2024 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·5 t sittenMuch is being written about crashes, interest rates, and all the things that might go wrong. I prefer to look at what Thor Medical has actually delivered – and where the company could stand in the coming years. AlphaOne was completed on time and on budget. Production has started, customers are receiving deliveries, and new multi-year agreements are coming in. Thor has around 850 million NOK in concluded delivery agreements, and the company expects increasing production and deliveries from AlphaOne. (thormedical.com) And this is not a small Norwegian experiment. Globally, massive investments are being made in targeted radioactive cancer treatment. Thor itself states that the number of published development programs based on Pb-212 and Ra-224 has more than doubled since 2025, and Pb-212 is now among the leading isotopes in the development of new alpha treatments. (thormedical.com) Companies are not doing this for fun. Billions are being invested because the clinical results in several places look promising. If Thor continues to deliver, and AlphaOne shows increasing sales through 2027, I personally do not think 7.50–10.00 NOK is an unrealistic scenario. Arctic has previously set a target price of 8.70 NOK before we have even seen the full commercial effect of AlphaOne. (Finansavisen) If larger contracts, higher production volume, and one or more Pb-212 treatments then move closer to commercial use, the market can begin to look much further ahead. Then, in my opinion, 10.00–15.00 NOK could become a relevant positive scenario – not a promise, but a possible outcome if the business develops strongly. AlphaOne is designed for approximately 21,000 patient doses and around 350 million NOK in annual revenue potential after three years of operation, and Thor expects EBITDA break-even in 2027. (thormedical.com) So yes, the market is restless right now, and some choose to sell. They are of course welcome to do that. I choose to look 1, 2, and 3 years ahead. Because if Thor continues to adhere to its plans, more customers join, and Pb-212 develops into the cancer treatment that so many companies worldwide are betting on, then I do not think the story of Thor Medical ends at 4 or 5 kroner. In my view, it has only just begun. And those who are left standing on the platform once the train has left must decide for themselves whether they want to run after it.
- ·1 päivä sittenCurious how much trmed will be affected by a potential crash.. feel they are a bit on the side, that they are not as dependent on the stock market as stocks in general. More and more (and more) (an) indicate that a crash could happen in the near future!! Considering selling out with GAV 2.92. Or will you sit tight in the event of a potential crash.. Some thoughts. ??When it went to hell last time, where did the boost come from. What went to heaven?
- ·2 päivää sitten(Guess I'll take one then) Ahhh, stocks on sale. That's the best thing I know, buy buy buy. Life is so loooovely❤️❤️❤️❤️ All I want is for stocks to go down so I get to buy buy buy. Because I have endless capital, that's why I am here on Nordnet. Oooooh, if only Thor had gone down below 3.8, then I would have bought even more. We'll have to count on that for Monday. Stocks that rise are for dopes. I want a downturn to buy more and more and more❤️ I never make a mistake, if I buy on sale now then I don't write that I am unlucky with my investments, but rather write a new post where I write that I buy even more. Because smart people buy more stocks when the stock plunges. Because I have read that Mr Warren Bucket does that. Happy weekend and cheers to stocks on sale!!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä |
|---|---|---|
| 10 852 | ||
| 10 000 | ||
| 1 500 | ||
| 7 648 | ||
| 4 899 |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastoja ja ETF:iä jotka omistavat osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Välittäjätilasto
Dataa ei löytynyt